title: Nucleus accumbens lesions modulate the effects of methylphenidate.
abstract: The psychostimulant methylphenidate (MPD, Ritalin) is the prescribed drug of choice for treatment of ADHD. In recent years, the diagnosis rate of ADHD has increased dramatically, as have the number of MPD prescriptions. Repeated exposure to psychostimulants produces behavioral sensitization in rats, an experimental indicator of a drug's potential liability. In studies on cocaine and amphetamine, this effect has been reported to involve the nucleus accumbens (NAc), one of the nuclei belonging to the motive circuit. The aim of this study was to investigate the role of the NAc on the expression of behavioral sensitization as a response to MPD exposure. In the present study, 20 male Sprague-Dawley rats were divided randomly into three groups: an intact control group, a sham-operated group, and a NAc bilateral electrical lesion group. Locomotor activity was assessed for the first 2h following 2.5mg/kg MPD injection, using open field monitoring systems. Recordings were made during 6 days of continuous MPD administration, and then upon re-challenge with the same dose following 3 days of washout. Acute MPD exposure elicited an increase in locomotor activity in all three groups. However, the NAc lesion group exhibited significantly increased locomotor activity in comparison to sham and control groups. Chronic MPD did not elicit sensitization in the NAc lesion group, while both sham and control groups did exhibit behavioral sensitization to repetitive MPD administration. These findings suggest that the NAc plays a significant role in eliciting locomotor activity as an acute effect of MPD, and in the expression of sensitization due to chronic MPD exposure.
authors.affiliation: Department of Neurobiology and Anatomy, The University of Texas-Medical School at Houston, P.O. Box 20708, Houston, TX 77225, United States.
authors.forename: Adam
authors.initials: A
authors.lastname: Podet
authors.forename: Min J
authors.initials: MJ
authors.lastname: Lee
authors.forename: Alan C
authors.initials: AC
authors.lastname: Swann
authors.forename: Nachum
authors.initials: N
authors.lastname: Dafny
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D009714:Nucleus Accumbens / Q000187:drug effects* / Q000293:injuries*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology; D013997:Time Factors
chemical_list: D000697:Central Nervous System Stimulants; D008774:Methylphenidate
references.citation: J Pediatr. 2001 Jan;138(1):6-9
references.pmid: 11148505
references.citation: Science. 1988 Nov 4;242(4879):715-23
references.pmid: 2903550
references.citation: J Neurosci. 1996 Feb 15;16(4):1550-60
references.pmid: 8778304
references.citation: Brain Res. 1985 Apr 29;333(1):169-72
references.pmid: 2859910
references.citation: Neuropharmacology. 2007 Jun;52(8):1596-605
references.pmid: 17459426
references.citation: Neuroscience. 1998 Sep;86(1):13-22
references.pmid: 9692739
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Pharmacol Biochem Behav. 2009 Mar;92(1):93-9
references.pmid: 19028517
references.citation: Pediatrics. 1999 Aug;104(2):e20
references.pmid: 10429138
references.citation: Pharmacol Biochem Behav. 1992 Nov;43(3):815-23
references.pmid: 1448477
references.citation: Behav Brain Res. 1998 Jul;94(1):127-52
references.pmid: 9708845
references.citation: Drug Alcohol Depend. 1995 May;38(2):95-137
references.pmid: 7671769
references.citation: JAMA. 1998 Apr 8;279(14):1100-7
references.pmid: 9546570
references.citation: Brain Res. 1996 Jul 15;727(1-2):13-21
references.pmid: 8842378
references.citation: Harv Rev Psychiatry. 1995 Jan-Feb;2(5):246-58
references.pmid: 9384909
references.citation: Life Sci. 2003 Oct 17;73(22):2899-911
references.pmid: 14511774
references.citation: J Learn Disabil. 1998 Nov-Dec;31(6):533-44
references.pmid: 9813951
references.citation: Neuropharmacology. 1983 Sep;22(9):1141-5
references.pmid: 6415508
references.citation: J Pharmacol Exp Ther. 1995 Oct;275(1):345-57
references.pmid: 7562570
references.citation: Neuropsychopharmacology. 2001 Nov;25(5):651-61
references.pmid: 11682248
references.citation: Brain Res Brain Res Rev. 1997 Oct;25(2):192-216
references.pmid: 9403138
references.citation: Behav Neurosci. 2006 Jun;120(3):600-11
references.pmid: 16768612
references.citation: Behav Brain Res. 1981 Nov;3(3):341-59
references.pmid: 6796098
references.citation: Eur J Pharmacol. 1976 Nov;40(1):45-56
references.pmid: 1033072
references.citation: Neuropharmacology. 2001;40(2):298-309
references.pmid: 11114409
references.citation: Behav Pharmacol. 1993;4(4):315-334
references.pmid: 11224200
references.citation: Psychopharmacology (Berl). 2007 Apr;191(3):705-17
references.pmid: 17031707
references.citation: Eur J Pharmacol. 2001 Aug 24;426(1-2):65-72
references.pmid: 11525772
references.citation: Neuropharmacology. 1989 Jan;28(1):9-14
references.pmid: 2927583
references.citation: Neuropharmacology. 2001 May;40(6):792-805
references.pmid: 11369033
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5664-9
references.pmid: 15064402
references.citation: Neurosci Biobehav Rev. 2000 Jan;24(1):133-6
references.pmid: 10654669
references.citation: Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
references.pmid: 2899326
references.citation: J Comp Neurol. 1996 May 20;369(1):1-15
references.pmid: 8723699
references.citation: Brain Res Brain Res Rev. 1991 Sep-Dec;16(3):223-44
references.pmid: 1665095
references.citation: Behav Brain Res. 1996 Nov;81(1-2):123-33
references.pmid: 8950008
references.citation: Pharmacol Biochem Behav. 1999 Aug;63(4):543-8
references.pmid: 10462182
references.citation: Life Sci. 1999;65(1):PL7-12
references.pmid: 10403500
references.citation: Pharmacol Biochem Behav. 1974 Mar-Apr;2(2):249-55
references.pmid: 4857295
references.citation: Synapse. 1999 May;32(2):119-31
references.pmid: 10231131
references.citation: Psychopharmacology (Berl). 1996 Oct;127(4):377-83
references.pmid: 8923575
references.citation: Neuropharmacology. 2009 Sep;57(3):201-7
references.pmid: 19540860
references.citation: Brain Res Bull. 2008 May 15;76(1-2):131-40
references.pmid: 18395622
references.citation: Eur J Pharmacol. 2000 Jan 24;388(1):69-76
references.pmid: 10657548
references.citation: Neurosci Biobehav Rev. 2000 Jan;24(1):125-32
references.pmid: 10654668
references.citation: J Neurochem. 1997 May;68(5):2032-7
references.pmid: 9109529
references.citation: Int J Neurosci. 2007 Jun;117(6):757-94
references.pmid: 17454243
references.citation: Pharmacol Biochem Behav. 2002 Jun;72(3):651-7
references.pmid: 12175462
references.citation: NIDA Res Monogr. 1998 Mar;169:56-82
references.pmid: 9686411
references.citation: J Pharmacol Exp Ther. 1994 Aug;270(2):690-6
references.pmid: 8071860
references.citation: Pediatrics. 2003 Jan;111(1):179-85
references.pmid: 12509574
references.citation: J Neurosci. 1990 Jan;10(1):303-10
references.pmid: 2299396
references.citation: Behav Brain Res. 2001 Nov 29;126(1-2):205-9
references.pmid: 11704265
references.citation: Life Sci. 1997;61(8):PL101-7
references.pmid: 9275016
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1178-87
references.pmid: 16507711
references.citation: Brain Res. 2000 May 2;864(1):24-39
references.pmid: 10793183
references.citation: Brain Res. 2008 Jun 5;1213:57-68
references.pmid: 18455710
references.citation: Brain Res. 2003 May 9;971(2):139-52
references.pmid: 12706230
references.citation: J Neurosci. 2003 Jul 16;23(15):6295-303
references.pmid: 12867514
references.citation: Int J Neurosci. 2009;119(1):40-58
references.pmid: 19116830
references.citation: Brain Res. 2006 Feb 16;1073-1074:164-74
references.pmid: 16473326
references.citation: J Pharmacol Exp Ther. 1988 Jun;245(3):1095-102
references.pmid: 3385638
references.citation: Behav Neurosci. 2009 Jun;123(3):577-88
references.pmid: 19485564
references.citation: Brain Res. 1990 May 14;516(1):99-106
references.pmid: 2364286
references.citation: J Pharmacol Exp Ther. 2001 Mar;296(3):876-83
references.pmid: 11181919
references.citation: Neuroscience. 1995 Mar;65(2):385-95
references.pmid: 7777156
references.citation: Behav Brain Res. 2002 Apr 1;131(1-2):9-16
references.pmid: 11844568
references.citation: Brain Res Bull. 2006 Feb 15;68(6):393-405
references.pmid: 16459193
references.citation: Psychopharmacology (Berl). 1991;104(1):140-1
references.pmid: 1882000
references.citation: Neurochem Int. 2009 Sep;55(5):318-22
references.pmid: 19576520
references.citation: J Neurosci. 1995 Sep;15(9):6287-99
references.pmid: 7666211
references.citation: Psychopharmacology (Berl). 2010 Feb;208(2):323-31
references.pmid: 19960188
references.citation: Brain Res Bull. 2009 Dec 16;80(6):353-8
references.pmid: 19729055
references.citation: Behav Brain Res. 2006 Jun 30;170(2):219-23
references.pmid: 16580740
references.citation: Life Sci. 1997;60(1):PL1-7
references.pmid: 8995535
references.citation: Life Sci. 2001 May 25;69(1):47-57
references.pmid: 11411804
references.citation: Psychopharmacology (Berl). 1999 Sep 1;146(1):93-100
references.pmid: 10485970
references.citation: Physiol Behav. 2000 Oct 1-15;71(1-2):133-45
references.pmid: 11134695
references.citation: Brain Res. 2007 May 11;1145:66-80
references.pmid: 17335781